Literature DB >> 6251943

Maintenance of isolated oligodendrocytes in long-term culture.

S Szuchet, K Stefansson, R L Wollmann, G Dawson, B G Arnason.   

Abstract

A new procedure for isolating oligodendrocytes from ovine white matter is described. The method separates oligodendrocytes into two bands on a linear sucrose gradient. Five criteria have been employed to classify the separated cells. It is shown by indirect immunofluorescence with specific antisera that 97% of the cells from both bands carry galactocerebroside, a specific surface marker for oligodendrocytes, on their plasma membranes and 95% of the cells retain myelin basic protein as distinct patches on their surfaces. Isolated cells conform ultrastructurally to current concepts of oligodendrocytes. The cells incorporate [3H]galactose into galactocerebroside and carrier free H2(35)SO4 into sulfatide, specific markers for oligodendrocytes. The specific activity of 2',3'-cyclic nucleotide-3'-phosphodiesterase in the two cell fractions is comparable to that reported for isolated oligodendrocytes by others. It is concluded that conservatively, 95% of the cells in both fractions are oligodendrocytes. Cells from both bands survive in culture for months. In vitro the cells extend two or more processes, contain 'gliosomes', and surround themselves with extensive sheet-like membranes; i.e. they exhibit the morphological characteristics ascribed to oligodendrocytes in explant cultures. Conservatively 90% of cultured cells stain with an antimyelin basic protein serum. The staining is localized in the cytoplasm and processes. The cells also stain with antigalactocerebroside and antioligodendrocyte sera. Cells remain differentiated for up to 70 days in vitro as evidenced by their incorporation of [3H]galactose and H2(35)SO4 into galactosyl and sulfogalactosylceramide, respectively.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251943     DOI: 10.1016/0006-8993(80)91101-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro.

Authors:  R P Saneto; A Altman; R L Knobler; H M Johnson; J de Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Characterization of cultured rat oligodendrocytes proliferating in a serum-free, chemically defined medium.

Authors:  R P Saneto; J de Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 3.  Cellular and molecular aspects of myelin protein gene expression.

Authors:  A T Campagnoni; W B Macklin
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

4.  Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes.

Authors:  P LoPresti; S Szuchet; S C Papasozomenos; R P Zinkowski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

5.  Schwann cell expression of a major myelin glycoprotein in the absence of myelin assembly.

Authors:  J F Poduslo; C T Berg; P J Dyck
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

6.  Gradient isolation of glial cells: evidence that flat epithelial cells are astroglial cell precursors.

Authors:  K Meller
Journal:  Cell Tissue Res       Date:  1987-07       Impact factor: 5.249

7.  Lipid metabolism of isolated oligodendrocytes maintained in long-term culture mimics events associated with myelinogenesis.

Authors:  S Szuchet; S H Yim; S Monsma
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

8.  Minisegments of newborn rat optic nerves in vitro: gliogenesis and myelination.

Authors:  F X Omlin; J Waldmeyer
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

9.  A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and on oligodendrocytes.

Authors:  D D Mikol; K Stefansson
Journal:  J Cell Biol       Date:  1988-04       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.